Simplex Trading’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-36,800
| Closed | -$20K | – | 11976 |
|
|
2021
Q4 | $20K | Buy |
36,800
+36,100
| +5,157% | +$1.03M | ﹤0.01% | 8385 |
|
|
2021
Q3 | $26K | Hold |
700
| – | – | ﹤0.01% | 8222 |
|
|
2021
Q2 | $26K | Buy |
700
+642
| +1,107% | +$19.7K | ﹤0.01% | 8363 |
|
|
2021
Q1 | $148K | Sell |
58
-1
| -2% | -$26 | ﹤0.01% | 5205 |
|
|
2020
Q4 | $129K | Sell |
59
-501
| -89% | -$11K | ﹤0.01% | 5166 |
|
|
2020
Q3 | $1.01M | Buy |
560
+559
| +55,900% | +$11.6K | ﹤0.01% | 2225 |
|
|
2020
Q2 | $2K | Sell |
1
-2
| -67% | -$43 | ﹤0.01% | 7309 |
|
|
2020
Q1 | $5K | Sell |
3
-124
| -98% | -$2.41K | ﹤0.01% | 6902 |
|
|
2019
Q4 | $279K | Buy |
127
+126
| +12,600% | +$2.54K | ﹤0.01% | 3379 |
|
|
2019
Q3 | $1K | Buy |
+1
| New | +$14 | ﹤0.01% | 7119 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | -$1K | – | 8132 |
|
|
2019
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 6989 |
|
|
2018
Q4 | $1K | Buy |
+1
| New | +$13 | ﹤0.01% | 6843 |
|
|
2018
Q3 | – | Sell |
-411
| Closed | -$503K | – | 8348 |
|
|
2018
Q2 | $503K | Buy |
+411
| New | +$5.16K | ﹤0.01% | 2452 |
|
Other funds holding DRNA
Simplex Trading's DRNA Position: Q4 2021 in Review
Simplex Trading sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 1,759 shares — an estimated $50K sold.
Simplex Trading first reported a position in DRNA in Q2 2018 and held it in 9 quarters. The position peaked at $636K in Q3 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Simplex Trading reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Simplex Trading sold 1,759 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $50K.
- Simplex Trading first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2018 and held it in 9 quarters.
- Simplex Trading's Dicerna Pharmaceuticals, Inc. position peaked at $636K in Q3 2020.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Simplex Trading's 13F filing for Q4 2021, filed 4 Feb 2022.